Wyeth Hit With Securities Suit Over Menopause Drug

Law360, New York (November 15, 2007, 12:00 AM EST) -- Wyeth has been slammed by a proposed shareholder class action alleging that the pharmaceuticals giant made false and misleading statements about its depression and menopause drug Pristiq.

The law firm Coughlin, Stoia, Geller, Rudman & Robbins LLP announced on Wednesday that it had lodged the lawsuit in the U.S. District Court in Manhattan, accusing Wyeth of hiding negative data about Pristiq's effects when it filed a New Drug Application in June 2006.

A spokesman for Wyeth declined to comment.

The lawsuit was filed on behalf of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.